Sho Takeda

Okayama, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 22 publications

ADAR1 as a prognostic marker for patients with colorectal cancer and synchronous liver metastasis and a predictor of chemotherapy efficacy.

ADAR1 as a prognostic marker for patients with colorectal cancer and synchronous liver metastasis and a predictor of chemotherapy efficacy.

Journal: Scientific reports

Published: April 11, 2025

ADAR1-high tumor-associated macrophages induce drug resistance and are therapeutic targets in colorectal cancer.

ADAR1-high tumor-associated macrophages induce drug resistance and are therapeutic targets in colorectal cancer.

Journal: Molecular cancer

Published: November 24, 2024

Predictive marker for response to trifluridine/tipiracil plus bevacizumab in metastatic colorectal cancer patients.

Predictive marker for response to trifluridine/tipiracil plus bevacizumab in metastatic colorectal cancer patients.

Journal: BMC cancer

Published: March 28, 2024

BRAF-mutant microsatellite-stable rectal cancer with acquired KRAS mutation leading to drug resistance in liver metastasis.

BRAF-mutant microsatellite-stable rectal cancer with acquired KRAS mutation leading to drug resistance in liver metastasis.

Journal: International cancer conference journal

Published: January 09, 2024

A Case Report of Non-typical Annular Pancreas Diagnosed during Laparoscopic Gastric Surgery.

A Case Report of Non-typical Annular Pancreas Diagnosed during Laparoscopic Gastric Surgery.

Journal: Acta medica Okayama

Published: February 27, 2023

Results of the interim analysis of a prospective, multicenter, observational study of small subepithelial lesions in the stomach.

Results of the interim analysis of a prospective, multicenter, observational study of small subepithelial lesions in the stomach.

Journal: Digestive endoscopy : official journal of the Japan Gastroenterological Endoscopy Society

Published: January 29, 2023

RNA Editing is a Valuable Biomarker for Predicting Carcinogenesis in Ulcerative Colitis.

RNA Editing is a Valuable Biomarker for Predicting Carcinogenesis in Ulcerative Colitis.

Journal: Journal of Crohn's & colitis

Published: December 18, 2022

ADAR1 is a promising risk stratification biomarker of remnant liver recurrence after hepatic metastasectomy for colorectal cancer.

ADAR1 is a promising risk stratification biomarker of remnant liver recurrence after hepatic metastasectomy for colorectal cancer.

Journal: Scientific reports

Published: November 09, 2022

A Case of a Transwoman with Colorectal Cancer after Flap Vaginoplasty.

A Case of a Transwoman with Colorectal Cancer after Flap Vaginoplasty.

Journal: Journal of plastic and reconstructive surgery

Published: May 19, 2022

RNA editing facilitates the enhanced production of neoantigens during the simultaneous administration of oxaliplatin and radiotherapy in colorectal cancer.

RNA editing facilitates the enhanced production of neoantigens during the simultaneous administration of oxaliplatin and radiotherapy in colorectal cancer.

Journal: Scientific reports

Published: February 23, 2022

Regulatory T cells induce a suppressive immune milieu and promote lymph node metastasis in intrahepatic cholangiocarcinoma.

Regulatory T cells induce a suppressive immune milieu and promote lymph node metastasis in intrahepatic cholangiocarcinoma.

Journal: British journal of cancer

Published: November 29, 2021

Surgical technique of suprapancreatic D2 lymphadenectomy focusing on the posterior hepatic plexus for advanced gastric cancer.

Surgical technique of suprapancreatic D2 lymphadenectomy focusing on the posterior hepatic plexus for advanced gastric cancer.

Journal: Langenbeck's archives of surgery

Published: June 23, 2021

Showing 1-12 of 22

Last Updated: 09/26/2026